The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Targeting the human genes that HIV takes over and uses to replicate could provide a new approach to HIV treatment and suppression – although more research is required.
HIV as a risk factor for diabetes has long been controversial, but new evidence shows that people living with HIV have increased diabetes prevalence compared to the general population.
The UK has exceeded UNAIDS Fast-Track targets of getting people on treatment and virally suppressed, but falls behind on reaching those who are undiagnosed.
Authorities in the Czech Republic have dropped their case against 30 HIV-positive gay men accused of having unprotected sex and spreading HIV – a criminal offence in the country.
Gay men living with HIV are 37 times more likely to develop anal cancer than HIV-negative gay men, but a lack of guidelines means these men don’t get screened.
The world’s fastest HIV testing kit is to be launched in the United Kingdom (UK) ahead of European HIV Testing Week (18-25 November).
The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.
Phase III trials of the intravenous drug ibalizumab have been found to significantly reduce viral load in people living with HIV who do not respond to existing treatment.
The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.